-

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The University of Texas Southwestern Medical Center and Medical Logix LLC. The University of Texas Southwestern Medical Center is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

The University of Texas Southwestern Medical Center designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.

NURSE, NURSE PRACTITIONER AND PA CREDIT RECIPROCITY

American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

American Association of Nurse Practitioners (AANP) National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

American Academy of PAs (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. PAs may receive a maximum of 1.5 credits of Category 1 for completing this program.

• Medical_Professionals
• Medical_students
• Nurses

This activity is intended for healthcare professionals, specifically, neurologists, internists, family practice physicians, nurse practitioners, physician assistants, nurses and other providers involved in the care of patients with multiple sclerosis.

LEARNING OBJECTIVES

After participating in this activity, the participant will demonstrate the ability to:

Explain the autoimmune basis of MS.

Discuss shared and unique pathophysiologic pathways between MS and other autoimmune diseases.

Outline mechanisms of action of current and investigational MS therapies.

List the major considerations associated with long-term immunosuppression in treating MS.

Outline strategies to address the consequences of long-term immunosuppression in treating MS.

As an accredited provider, UT Southwestern Medical Center requires that the content of our activities are:

Independent, objective, scientifically rigorous, balanced and free of bias.

Based on scientific studies utilized or referenced from sources acceptable to the scientific and medical community.

Acceptable to the medical community as it relates to patient recommendations and do not recommend any unscientific modalities or those not supported by evidenced based sources.

Benjamin M. Greenberg, MD, MHS 

Vice Chair of Translational Research and Ambulatory Care 

Department of Neurology and Neurotherapeutics 

Director, Transverse Myelitis, Neuromyelitis Optica Programs 

Co-Director, Pediatric CONQUER Program 

UT Southwestern Medical Center 

Childrens Health 

Dallas, TX

Julius Birnbaum, MD, MHS 

Assistant Professor of Medicine 

Department of Neurology and Division of Rheumatology 

Associate Director 

Johns Hopkins Jerome L. Greene Sjögren's Center 

Johns Hopkins University School of Medicine 

Baltimore, MD

Bruce Cree, MD, PhD, MAS

Associate Professor of Clinical Neurology

Multiple Sclerosis Center Clinical Research Director

University of California, San Francisco

San Francisco, CA

Reviewer:

Shaida Khan, DO

Assistant Instructor

Department of Neurology and Neurotherapeutics

UT Southwestern Medical Center

Dallas, TX

USD

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Submission Info

Postgraduate Institute for Medicine

304 Inverness Way South, Suite 100

Englewood, Colorado 80112

Phone: (303) 799-1930

Postgraduate Institute for Medicine

304 Inverness Way South, Suite 100

Englewood, Colorado 80112

Phone: (303) 799-1930